Filing Details
- Accession Number:
- 0001181431-13-059721
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-19 19:01:19
- Reporting Period:
- 2013-11-15
- Filing Date:
- 2013-11-19
- Accepted Time:
- 2013-11-19 19:01:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1162194 | Fluidigm Corp | FLDM | Laboratory Analytical Instruments (3826) | 770513190 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380208 | T Fredric Walder | Fluidigm Corporation 7000 Shoreline Court, Suite 100 South San Francisco CA 94080 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-15 | 1,500 | $4.45 | 1,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-15 | 1,500 | $30.33 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-11-15 | 1,500 | $0.00 | 1,500 | $4.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,727 | 2020-08-26 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Walder were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2013.
- 25% of the shares subject to the Option vested on May 17, 2011, and 1/48th of the shares subject to the Option shall vest monthly thereafter.